1. Klinicheskij protokol MZ RK Nefroblastoma u detej. Odobreno Ob#edinennoj komissiej po kachestvu medicinskih uslug Ministerstva zdravoohranenija i social'nogo razvitija Respubliki Kazahstan ot «13»ijulja 2016 goda Protokol №7.
2. Kuleva S.A., Imjanitov E.N. Opuhol' Vil'msa: sindromal'naja i molekuljarnaja diagnostika. Onkopediatrija. 2017; 4(4):283–289. Doi: 10.15690/onco.v4i4.1814)
3. Dome J.S., Graf N., Geller J.I., Fernandez C.V., Mullen E.A., Spreafico F.,Van den Heuvel-Eibrink M, Pritchard-Jones K: Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Sep 20; 33: 2999 [PMID: 26304882]
4. Ehrlich P., Chi Y.Y., Chintagumpala M.M.et al. Results of the First Prospective Multi-insti- tutional Treatment Study in Children With Bilat- eral Wilms Tumor (AREN0534): A Report From the Children’s Oncology Group. Ann Surg 2017;266(3):470–8. doi: 10.1097/ SLA.0000000000002356.
5. Erdmann F., Kaatsch P., Grabow D., Spix C.: German Childhood Cancer Registry – Annual Report 2019 (1980-2018). Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz 2020 [URI: https://www.kinderkrebsregister.de/typo3temp/secure_downloads/42507/0/1c5976c2ab8af5b6b388149df7182582a4cd6a39/Buch_DKKR_Jahresbericht_2019_komplett.pdf